<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet href="/rss.css" type="text/css"?>
<rdf:RDF xmlns="http://purl.org/rss/1.0/"
    xmlns:cc="http://web.resource.org/cc/"
    xmlns:dc="http://purl.org/dc/elements/1.1/"
    xmlns:extra="http://www.w3.org/1999/xhtml"
    xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/"
    xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#">
    <channel rdf:about="http://www.biomedcentral.com/feeds/latestarticles/journal?journal=bmcpregnancychildbirth&amp;quantity=&amp;format=rss&amp;version=">
        <title>BMC Pregnancy and Childbirth - Latest Articles</title>
        <link>http://www.biomedcentral.com/bmcpregnancychildbirth/</link>
        <description>The latest research articles published by BMC Pregnancy and Childbirth</description>
        <dc:date>2009-07-09T00:00:00Z</dc:date>
        <items>
            <rdf:Seq>
                                <rdf:li rdf:resource="http://www.biomedcentral.com/1471-2393/9/28" />
                                <rdf:li rdf:resource="http://www.biomedcentral.com/1471-2393/9/27" />
                                <rdf:li rdf:resource="http://www.biomedcentral.com/1471-2393/9/26" />
                                <rdf:li rdf:resource="http://www.biomedcentral.com/1471-2393/9/25" />
                                <rdf:li rdf:resource="http://www.biomedcentral.com/1471-2393/9/24" />
                                <rdf:li rdf:resource="http://www.biomedcentral.com/1471-2393/9/23" />
                                <rdf:li rdf:resource="http://www.biomedcentral.com/1471-2393/9/22" />
                                <rdf:li rdf:resource="http://www.biomedcentral.com/1471-2393/9/21" />
                                <rdf:li rdf:resource="http://www.biomedcentral.com/1471-2393/9/20" />
                                <rdf:li rdf:resource="http://www.biomedcentral.com/1471-2393/9/19" />
                            </rdf:Seq>
        </items>
        <extra:info rdf:parseType="Literal">
            <html:div style="font:14px Verdana, Geneva, Arial, Helvetica, sans-serif" xmlns:html="http://www.w3.org/1999/xhtml">
                <html:span style="font-weight:bold">
                    This is an RSS newsfeed from BioMed Central
                </html:span>
                <html:br />
                <html:span style="font-size: 12px;">
                    It is intended to be used with an RSS reader. For more information about RSS newsfeeds from BioMed Central, visit
                    <html:br />
                    <html:a href="http://www.biomedcentral.com/info/about/rss/" style="color:#3333CC; font-size:12px;">
                        http://www.biomedcentral.com/info/about/rss/
                    </html:a>
                    <html:br />
                </html:span>
            </html:div>
        </extra:info>
        <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </channel>
        <item rdf:about="http://www.biomedcentral.com/1471-2393/9/28">
        <title>Knowledge and utilization of intermittent  preventive  treatment for malaria among  pregnant women  attending  antenatal  clinics  in  primary health  care  centers  in   rural   southwest, Nigeria: a  cross-sectional study </title>
        <description>Background:
Intermittent preventive treatment for prevention of malaria in pregnancy (IPTp) is a key component of malaria control strategy in Nigeria and sulfadoxine-pyrimethamine (SP) is the drug of choice.  Despite the evidence of the effectiveness of IPTp strategy using SP in reducing the adverse effects of malaria during pregnancy the uptake and coverage in Nigeria is low. This study set out to assess the use of IPTp among pregnant women attending primary health centres in the rural area and determine factors that influence the uptake.
Methods:
A cross-sectional study was carried out between July and August 2007 among 209 pregnant women selected by systematic random sampling from antenatal care attendees at primary health care in a rural Local Government Area of Ekiti State, Nigeria. Information on knowledge of IPT,  delivery,  adherence  and  acceptability  was  obtained  using  an  interviewer  administered questionnaire. Descriptive statistics such as means, range, proportions were used.  Chi-square test was used to examine association between categorical variables. All analyses were performed at 5% level of significance.Result: One  hundred  and  nine  of  209  (52.2%)  respondents  have  heard  about  IPTp  but  only  26 (23.9%) were able to define it. Fifty seven (27.3%) reported to have received at least one dose of IPTp during the index pregnancy and all were among those who have heard of IPTp (52.3%). Twenty one of the 57 (36.8%) took the SP in the clinic. Only three of the twenty-one (14.3%) were supervised by a health worker. Twenty two of the 36 women (61.1%) who did not take their drugs in the clinic would have liked to do so if allowed to bring their own drinking cups. Almost  half  (43.9%)  of  those who  had  used  IPTp  during  the  index pregnancy  expressed  concern  about  possible  adverse  effect  of SP  on  their  pregnancies. Periodic shortages of SP in the clinics were also reported.
Conclusion:
In this study, IPTp use among pregnant women was very low and there was poor adherence to the Directly Observed Therapy (DOT) scheme. Concerted effort should be made to increase awareness of IPTp among the public especially women of child bearing age. Health workers should also be trained and monitored to ensure adherence.</description>
        <link>http://www.biomedcentral.com/1471-2393/9/28</link>
                <dc:creator>Stella Akinleye</dc:creator>
                <dc:creator>Catherine Falade</dc:creator>
                <dc:creator>Ikeoluwapo Ajayi</dc:creator>
                <dc:source>BMC Pregnancy and Childbirth 2009, 9:28</dc:source>
        <dc:date>2009-07-09T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1471-2393-9-28</dc:identifier>
        <prism:publicationName>BMC Pregnancy and Childbirth</prism:publicationName>
        <prism:issn>1471-2393</prism:issn>
        <prism:volume>9</prism:volume>
        <prism:startingPage>28</prism:startingPage>
        <prism:publicationDate>2009-07-09T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>PDF</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.biomedcentral.com/1471-2393/9/27">
        <title>Experiences of professional support during pregnancy and childbirth - a qualitative study of women with type 1 diabetes </title>
        <description>Background:
Women with type 1 diabetes are at high risk of complications during both pregnancy and childbirth. Stringent monitoring of blood sugar is required in order to improve the chance of giving birth to a healthy child; however, this increases the incidence of severe hypoglycaemia.  The aim of this study was to explore their need for and experience of professional support during pregnancy and childbirth.
Methods:
The study has a lifeworld research approach. Six focus groups and four individual interviews were conducted with 23 women, 6- 24 months after delivery.  The participants were encouraged to narrate their experiences of pregnancy and childbirth in relation to glycaemic control, well-being and provided care. Data analysis was directed towards discovering qualitative meanings by identifying and clustering meaning units in the text. Further analysis identified eight themes of meaning, classified under pregnancy or childbirth, forming a basis for a final whole interpretation of the explored phenomenon.
Results:
The women felt worry about jeopardizing the baby&apos;s health and this was sometimes made worse by care providers&apos; manner and lack of competence and support. The increased attention from care providers during pregnancy was experienced as related to the health of the unborn child; not the mothers. Women who during pregnancy received care in a disconnected diabetes organisation were forced to act as messengers between different care providers.
Conclusions:
Clarity in terms of defining responsibilities is necessary during pregnancy and childbirth, both among care providers and between the woman and the care provider. Furthermore, a decision must be made concerning how to delegate, transfer or share diabetes responsibility during labour between the care providers and the parents-to-be.</description>
        <link>http://www.biomedcentral.com/1471-2393/9/27</link>
                <dc:creator>Marie Berg</dc:creator>
                <dc:creator>Carina Sparud-Lundin</dc:creator>
                <dc:source>BMC Pregnancy and Childbirth 2009, 9:27</dc:source>
        <dc:date>2009-07-03T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1471-2393-9-27</dc:identifier>
        <prism:publicationName>BMC Pregnancy and Childbirth</prism:publicationName>
        <prism:issn>1471-2393</prism:issn>
        <prism:volume>9</prism:volume>
        <prism:startingPage>27</prism:startingPage>
        <prism:publicationDate>2009-07-03T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>PDF</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.biomedcentral.com/1471-2393/9/26">
        <title>Epidemiology of nausea and vomiting of pregnancy: prevalence, severity, determinants, and the importance of race/ethnicity.</title>
        <description>Background:
Studies that contributed to the epidemiology of nausea and vomiting of pregnancy have reported conflicting findings, and often failed to account for all possible co-variables necessary to evaluate the multidimensional associations. The objectives of this study were to: 1) Estimate the prevalence and the severity of nausea and vomiting of pregnancy during the 1st and the 2nd trimester of pregnancy, and 2) Identify determinants of presence and severity of nausea and vomiting of pregnancy during the 1st and 2nd trimesters separately, with a special emphasis on the impact of race/ethnicity.
Methods:
A prospective study including pregnant women attending the Centre Hospitalier Universitaire (CHU) Sainte-Justine or Rene-Laennec clinics for their prenatal care was conducted from 2004 to 2006. Women were eligible if they were at least 18 years of age, and 16 weeks of gestation or less. Women were asked to fill out a 1st trimester self-administered questionnaire and were interviewed over the telephone during their 2nd trimester of pregnancy. Presence of nausea and vomiting of pregnancy was based on the reporting of pregnant women (yes/no); severity of symptoms was measured by the validated modified-PUQE index.
Results:
Of the 367 women included in the study, 81.2% were Caucasians, 10.1% Blacks, 4.6% Hispanics, and 4.1% Asians. Multivariate analyses showed that race/ethnicity was significantly associated with a decreased likelihood of reporting nausea and vomiting of pregnancy (Asians vs. Caucasians OR: 0.13; 95%CI 0.02-0.73; and Blacks vs. Caucasians OR: 0.29; 95%CI 0.09-0.99).
Conclusions:
Our study showed that race/ethnicity was associated with the reporting of nausea and vomiting of pregnancy in the 1st trimester of pregnancy.</description>
        <link>http://www.biomedcentral.com/1471-2393/9/26</link>
                <dc:creator>Anais Lacasse</dc:creator>
                <dc:creator>Evelyne Rey</dc:creator>
                <dc:creator>Ema Ferreira</dc:creator>
                <dc:creator>Caroline Morin</dc:creator>
                <dc:creator>Anick Berard</dc:creator>
                <dc:source>BMC Pregnancy and Childbirth 2009, 9:26</dc:source>
        <dc:date>2009-07-02T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1471-2393-9-26</dc:identifier>
        <prism:publicationName>BMC Pregnancy and Childbirth</prism:publicationName>
        <prism:issn>1471-2393</prism:issn>
        <prism:volume>9</prism:volume>
        <prism:startingPage>26</prism:startingPage>
        <prism:publicationDate>2009-07-02T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>PDF</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.biomedcentral.com/1471-2393/9/25">
        <title>Births in two different delivery units in the same clinic - A prospective study of healthy primiparous women</title>
        <description>Background:
Earlier studies indicate that midwife-led birth settings are associated with modest benefits, including reduced medical interventions and increased maternal satisfaction. The generalizability of these studies to birth settings with low intervention rates, like those generally found in Norway, is not obvious.  The aim of the present study was to compare intervention rates associated with labour in low-risk women who begin their labour in a midwife-led unit and a conventional care unit.
Methods:
Eligible participants were low-risk primiparas who met the criteria for delivery in the midwife-led ward regardless of which cohort they were allocated to. The two wards are localised at the same floor. Women in both cohorts received the same standardized public antenatal care by general medical practitioners and midwifes who were not involved in the delivery. After admission of a woman to the midwife-led ward, the next woman who met the inclusion criteria, but preferred delivery at the conventional delivery ward, was allocated to the conventional delivery ward cohort. Among the 252 women in the midwife-led ward cohort, 74 (29%) women were transferred to the conventional delivery ward during labour.        Results: Emergency caesarean and instrumental delivery rates in women who were admitted to the midwife-led and conventional birth wards were statistically non-different, but more women admitted to the conventional birth ward had episiotomy. More women in the conventional delivery ward received epidural analgesia, pudental nerve block and nitrous oxide, while more women in the midwife-led ward received opiates and non-pharmacological pain relief.
Conclusion:
We did not find evidence that starting delivery in the midwife-led setting offers the advantage of lower operative delivery rates. However, epidural analgesia, pudental nerve block and episiotomies were less often while non-pharmacological pain relief was often used in the midwife-led ward.</description>
        <link>http://www.biomedcentral.com/1471-2393/9/25</link>
                <dc:creator>Britt Ingeborg Eide</dc:creator>
                <dc:creator>Anne Britt Vika Nilsen</dc:creator>
                <dc:creator>Svein Rasmussen</dc:creator>
                <dc:source>BMC Pregnancy and Childbirth 2009, 9:25</dc:source>
        <dc:date>2009-06-22T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1471-2393-9-25</dc:identifier>
        <prism:publicationName>BMC Pregnancy and Childbirth</prism:publicationName>
        <prism:issn>1471-2393</prism:issn>
        <prism:volume>9</prism:volume>
        <prism:startingPage>25</prism:startingPage>
        <prism:publicationDate>2009-06-22T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>PDF</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.biomedcentral.com/1471-2393/9/24">
        <title>An evaluation of classification systems for stillbirth </title>
        <description>Background:
Audit and classification of stillbirths is an essential part of clinical practice and a crucial step towards stillbirth prevention. Due to the limitations of the ICD system and lack of an international approach to an acceptable solution, numerous disparate classification systems have emerged. We assessed the performance of six contemporary systems to inform the development of an internationally accepted approach.
Methods:
We evaluated the following systems: Amended Aberdeen, Extended Wigglesworth; PSANZ-PDC, ReCoDe, Tulip and CODAC. Nine teams from 7 countries applied the classification systems to cohorts of stillbirths from their regions using 857 stillbirth cases. The main outcome measures were: the ability to retain the important information about the death using the InfoKeep rating; the ease of use according to the Ease rating (both measures used a five-point scale with a score &lt;2 considered unsatisfactory); inter-observer agreement and the proportion of unexplained stillbirths. A randomly selected subset of 100 stillbirths was used to assess inter-observer agreement.
Results:
InfoKeep scores were significantly different across the classifications (p &#8804; 0.01) due to low scores for Wigglesworth and Aberdeen. CODAC received the highest mean (SD) score of 3.40 (0.73) followed by PSANZ-PDC, ReCoDe and Tulip [2.77 (1.00), 2.36 (1.21), 1.92 (1.24) respectively]. Wigglesworth and Aberdeen resulted in a high proportion of unexplained stillbirths and CODAC and Tulip the lowest. While Ease scores were different (p &#8804; 0.01), all systems received satisfactory scores; CODAC received the highest score. Aberdeen and Wigglesworth showed poor agreement with kappas of 0.35 and 0.25 respectively. Tulip performed best with a kappa of 0.74. The remainder had good to fair agreement.
Conclusion:
The Extended Wigglesworth and Amended Aberdeen systems cannot be recommended for classification of stillbirths. Overall, CODAC performed best with PSANZ-PDC and ReCoDe performing well. Tulip was shown to have the best agreement and a low proportion of unexplained stillbirths. The virtues of these systems need to be considered in the development of an international solution to classification of stillbirths. Further studies are required on the performance of classification systems in the context of developing countries. Suboptimal agreement highlights the importance of instituting measures to ensure consistency for any classification system.</description>
        <link>http://www.biomedcentral.com/1471-2393/9/24</link>
                <dc:creator>Vicki Flenady</dc:creator>
                <dc:creator>J. Frederik Froen</dc:creator>
                <dc:creator>Halit Pinar</dc:creator>
                <dc:creator>Rozbeh Torabi</dc:creator>
                <dc:creator>Eli Saastad</dc:creator>
                <dc:creator>Grace Guyon</dc:creator>
                <dc:creator>Laurie Russell</dc:creator>
                <dc:creator>Adrian Charles</dc:creator>
                <dc:creator>Catherine Harrison</dc:creator>
                <dc:creator>Lawrence Chauke</dc:creator>
                <dc:creator>Robert Pattinson</dc:creator>
                <dc:creator>Rachel Koshy</dc:creator>
                <dc:creator>Safiah Bahrin</dc:creator>
                <dc:creator>Glenn Gardener</dc:creator>
                <dc:creator>Katie Day</dc:creator>
                <dc:creator>Karin Petersson</dc:creator>
                <dc:creator>Adrienne Gordon</dc:creator>
                <dc:creator>Kristen Gilshenan</dc:creator>
                <dc:source>BMC Pregnancy and Childbirth 2009, 9:24</dc:source>
        <dc:date>2009-06-19T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1471-2393-9-24</dc:identifier>
        <prism:publicationName>BMC Pregnancy and Childbirth</prism:publicationName>
        <prism:issn>1471-2393</prism:issn>
        <prism:volume>9</prism:volume>
        <prism:startingPage>24</prism:startingPage>
        <prism:publicationDate>2009-06-19T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.biomedcentral.com/1471-2393/9/23">
        <title>Atosiban versus betamimetics in the treatment of preterm labour in Germany: an economic evaluation.</title>
        <description>Background:
The use of tocolytics is central in delaying birth; however, therapeutic options vary in effectiveness and adverse events profiles, which in turn could have consequences for medical resource use and cost of treatment.Betamimetics are commonly used tocolytic agents, but their mechanism of action affects multiple organ systems leading to numerous adverse events. The availability of an oxytocin receptor antagonist, specific for prevention of preterm labour, offers a treatment option that merits further evaluation. We aimed to compare economic implications of tocolysis using atosiban and betamimetics, considering treatment efficacy and safety, as well as cost consequences of treatment of associated adverse events.
Methods:
A systematic literature review identified six randomised clinical trials, three of them double-blinded, comparing atosiban with betamimetics, in which tocolysis was initiated within 48 hours of admission. Cost of drug treatment was calculated based on trial protocols and German hospital drug purchase costs. G-DRG Grouper was used to obtain cost per case. The drug regimen was concordant with the German guidelines for the management of preterm labour, with two alternative modalities of fenoterol analysed: continuous or bolus administrations.
Results:
According to the results of the meta-analysis of the three double-blinded, placebo-controlled clinical trials, atosiban and betamimetics have similar efficacy (RR = 0.99, 95%CI:0.94&#8211;1.04, p = 0.772). Compared to betamimetics, use of atosiban was associated with a significantly lower frequency of adverse events for tachycardia, palpitation, vomiting, headache, hyperglycaemia, tremor, dyspnoea, chest pain, hypocalemia and foetal tachycardia.In our economic analysis, cost savings from using atosiban versus continuous, or bolus, fenoterol was 423&#8364; per patient from the payer&apos;s perspective. From the hospital&apos;s perspective, savings from using atosiban versus continuous fenoterol ranged from 259&#8364; for 18 hours of tocolysis to 105&#8364; for 48 hours; the respective values for bolus fenoterol were 244&#8364; and 55&#8364;. In the probabilistic sensitivity analysis atosiban was cost saving versus both continuous and bolus fenoterol in 87%&#8211;100% of scenarios.
Conclusion:
In a German setting, atosiban is cost saving versus betamimetics in the treatment of preterm labour from the payer, hospital and combined perspectives. Cost savings stem from the superior safety profile of atosiban.</description>
        <link>http://www.biomedcentral.com/1471-2393/9/23</link>
                <dc:creator>Jaro Wex</dc:creator>
                <dc:creator>Mark Connolly</dc:creator>
                <dc:creator>Werner Rath</dc:creator>
                <dc:source>BMC Pregnancy and Childbirth 2009, 9:23</dc:source>
        <dc:date>2009-06-19T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1471-2393-9-23</dc:identifier>
        <prism:publicationName>BMC Pregnancy and Childbirth</prism:publicationName>
        <prism:issn>1471-2393</prism:issn>
        <prism:volume>9</prism:volume>
        <prism:startingPage>23</prism:startingPage>
        <prism:publicationDate>2009-06-19T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.biomedcentral.com/1471-2393/9/22">
        <title>Causes of death and associated conditions (Codac) - a utilitarian approach to the classification of perinatal deaths</title>
        <description>A carefully classified dataset of perinatal mortality will retain the most significant information on the causes of death. Such information is needed for health care policy development, surveillance and international comparisons, clinical services and research. For comparability purposes, we propose a classification system that could serve all these needs, and be applicable in both developing and developed countries. It is developed to adhere to basic concepts of underlying cause in the International Classification of Diseases (ICD), although gaps in ICD prevent classification of perinatal deaths solely on existing ICD codes.We tested the Causes of Death and Associated Conditions (Codac) classification for perinatal deaths in seven populations, including two developing country settings. We identified areas of potential improvements in the ability to retain existing information, ease of use and inter-rater agreement. After revisions to address these issues we propose Version II of Codac with detailed coding instructions.The ten main categories of Codac consist of three key contributors to global perinatal mortality (intrapartum events, infections and congenital anomalies), two crucial aspects of perinatal mortality (unknown causes of death and termination of pregnancy), a clear distinction of conditions relevant only to the neonatal period and the remaining conditions are arranged in the four anatomical compartments (fetal, cord, placental and maternal).For more detail there are 94 subcategories, further specified in 577 categories in the full version. Codac is designed to accommodate both the main cause of death as well as two associated conditions. We suggest reporting not only the main cause of death, but also the associated relevant conditions so that scenarios of combined conditions and events are captured.The appropriately applied Codac system promises to better manage information on causes of perinatal deaths, the conditions associated with them, and the most common clinical scenarios for future study and comparisons.</description>
        <link>http://www.biomedcentral.com/1471-2393/9/22</link>
                <dc:creator>J Frederik Froen</dc:creator>
                <dc:creator>Halit Pinar</dc:creator>
                <dc:creator>Vicki Flenady</dc:creator>
                <dc:creator>Safiah Bahrin</dc:creator>
                <dc:creator>Adrian Charles</dc:creator>
                <dc:creator>Lawrence Chauke</dc:creator>
                <dc:creator>Katie Day</dc:creator>
                <dc:creator>Charles Duke</dc:creator>
                <dc:creator>Fabio Facchinetti</dc:creator>
                <dc:creator>Ruth Fretts</dc:creator>
                <dc:creator>Glenn Gardener</dc:creator>
                <dc:creator>Kristen Gilshenan</dc:creator>
                <dc:creator>Sanne Gordijn</dc:creator>
                <dc:creator>Adrienne Gordon</dc:creator>
                <dc:creator>Grace Guyon</dc:creator>
                <dc:creator>Catherine Harrison</dc:creator>
                <dc:creator>Rachel Koshy</dc:creator>
                <dc:creator>Robert Pattinson</dc:creator>
                <dc:creator>Karin Petersson</dc:creator>
                <dc:creator>Laurie Russell</dc:creator>
                <dc:creator>Eli Saastad</dc:creator>
                <dc:creator>Gordon Smith</dc:creator>
                <dc:creator>Rozbeh Torabi</dc:creator>
                <dc:source>BMC Pregnancy and Childbirth 2009, 9:22</dc:source>
        <dc:date>2009-06-10T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1471-2393-9-22</dc:identifier>
        <prism:publicationName>BMC Pregnancy and Childbirth</prism:publicationName>
        <prism:issn>1471-2393</prism:issn>
        <prism:volume>9</prism:volume>
        <prism:startingPage>22</prism:startingPage>
        <prism:publicationDate>2009-06-10T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.biomedcentral.com/1471-2393/9/21">
        <title>Postpartum mental health after Hurricane Katrina: A cohort study</title>
        <description>Background:
Natural disaster is often a cause of psychopathology, and women are vulnerable to post-traumatic stress disorder (PTSD) and depression. Depression is also common after a woman gives birth. However, no research has addressed postpartum women&apos;s mental health after natural disaster.
Methods:
Interviews were conducted in 2006&#8211;2007 with women who had been pregnant during or shortly after Hurricane Katrina. 292 New Orleans and Baton Rouge women were interviewed at delivery and 2 months postpartum. Depression was assessed using the Edinburgh Depression Scale and PTSD using the Post-Traumatic Stress Checklist. Women were asked about their experience of the hurricane with questions addressing threat, illness, loss, and damage. Chi-square tests and log-binomial/Poisson models were used to calculate associations and relative risks (RR).
Results:
Black women and women with less education were more likely to have had a serious experience of the hurricane. 18% of the sample met the criteria for depression and 13% for PTSD at two months postpartum. Feeling that one&apos;s life was in danger was associated with depression and PTSD, as were injury to a family member and severe impact on property. Overall, two or more severe experiences of the storm was associated with an increased risk for both depression (relative risk (RR) 1.77, 95% confidence interval (CI) 1.08&#8211;2.89) and PTSD (RR 3.68, 95% CI 1.80&#8211;7.52).
Conclusion:
Postpartum women who experience natural disaster severely are at increased risk for mental health problems, but overall rates of depression and PTSD do not seem to be higher than in studies of the general population.</description>
        <link>http://www.biomedcentral.com/1471-2393/9/21</link>
                <dc:creator>Emily Harville</dc:creator>
                <dc:creator>Xu Xiong</dc:creator>
                <dc:creator>Gabriella Pridjian</dc:creator>
                <dc:creator>Karen Elkind-Hirsch</dc:creator>
                <dc:creator>Pierre Buekens</dc:creator>
                <dc:source>BMC Pregnancy and Childbirth 2009, 9:21</dc:source>
        <dc:date>2009-06-08T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1471-2393-9-21</dc:identifier>
        <prism:publicationName>BMC Pregnancy and Childbirth</prism:publicationName>
        <prism:issn>1471-2393</prism:issn>
        <prism:volume>9</prism:volume>
        <prism:startingPage>21</prism:startingPage>
        <prism:publicationDate>2009-06-08T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.biomedcentral.com/1471-2393/9/20">
        <title>Neonatal care in rural Karnataka: healthy and harmful practices, the potential for change</title>
        <description>Background:
Every year four million babies die in the first month of life and a quarter of these take place in India. A package of essential newborn care practices exists, which has a proven impact on reducing mortality, and can be implemented in low resource settings. However, childbirth and the neonatal period are culturally important times, during which there is strong adherence to traditional practices. Successful implementation of the package therefore requires in-depth knowledge of the local context and tailored behaviour change communication.
Methods:
This study was carried out in rural Karnataka, India. It uses quantitative data from a prospective survey following mothers through their experience of pregnancy and the postnatal period; and qualitative data from in depth interviews and focus group discussions conducted with mothers, grandmothers and birth attendants. It explores local newborn care practices and beliefs, analyses their harmful or beneficial characteristics and elucidates areas of potential resistance to behaviour change and implementation of the essential newborn care package.
Results:
Findings show that many potentially harmful newborn care practices are being carried out in the study area, such as unhygienic cord cutting, delayed breastfeeding and early bathing. Some are more amenable to change than others, depending on the strength of the underlying beliefs, and acceptability of alternative care. However, movement away from traditional practices is already taking place, particularly amongst the more educated and better off, and there is a clear opportunity to broaden, direct and accelerate this process.
Conclusion:
Community education should be a focus of the National Rural Health Mission (NRHM) and Integrated Management of Neonatal and Childhood Illness (IMNCI) program being implemented in Karnataka. The added capacity of the new Accredited Social Health Activists (ASHAs) could enable more women to be reached. With careful tailoring of behaviour change messages to the local context, government outreach workers can become effective brokers of positive change and significant improvements in home newborn care and neonatal mortality are possible.</description>
        <link>http://www.biomedcentral.com/1471-2393/9/20</link>
                <dc:creator>Amy Kesterton</dc:creator>
                <dc:creator>John Cleland</dc:creator>
                <dc:source>BMC Pregnancy and Childbirth 2009, 9:20</dc:source>
        <dc:date>2009-05-20T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1471-2393-9-20</dc:identifier>
        <prism:publicationName>BMC Pregnancy and Childbirth</prism:publicationName>
        <prism:issn>1471-2393</prism:issn>
        <prism:volume>9</prism:volume>
        <prism:startingPage>20</prism:startingPage>
        <prism:publicationDate>2009-05-20T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <item rdf:about="http://www.biomedcentral.com/1471-2393/9/19">
        <title>Pilot study for a trial of ursodeoxycholic acid (UDCA) and/or early delivery for obstetric cholestasis</title>
        <description>Background:
Obstetric cholestasis (OC) is a serious problem in pregnancy. It affects about 4500 women per year in the UK. Affected women develop itching and occasionally jaundice. More importantly, the condition is associated with premature delivery, fetal distress and is believed to be an important cause of stillbirth. However, even now, there is no clear evidence as to whether the most popular treatment, a drug called ursodeoxycholic acid is beneficial to the baby, or even if it is safe in pregnancy. Nor do we know whether planned early delivery of the baby at 37&#8211;38 weeks, another popular treatment, does more good than harm. A randomised trial to evaluate both ursodeoxycholic acid and timed delivery is needed but will be complicated and expensive. We plan a preliminary study, Pilot study for a trial of ursodeoxycholic acid and/or early delivery for obstetric cholestasis (Acronym PITCH- Pregnancy Intervention Trial in Cholestasis) trial, to evaluate the feasibility of a larger trial. The trial is funded by the NHS Research for Patient Benefit (RfPB) Programme.
Methods:
PITCH is a multi-centre, double blinded, randomised, controlled, factorial design trial. The trial is being run in six UK centres and women with obstetric cholestasis will be recruited for eighteen months. In this pilot trial we aim to collect data to finalise the design for the main trial. This will include measuring trial recruitment rate, including recruitment to each factorial comparison separately. We will also measure the spectrum of disease among recruits and non-recruits and compliance with the four possible treatment allocations. We will use these data to design the main trial.DiscussionThe ultimate aim of the main trial is to enable clinicians to manage this condition more effectively. If it transpires that ursodeoxycholic acid and early delivery are both safe and effective then steps will be taken to ensure that all women with OC who could benefit from them receives this treatment. Conversely, if one or both the treatments turn out to be ineffective or even harmful, they will be stopped and researchers will work at developing other modes of treatment.Trial registration numberISRCTN37730443</description>
        <link>http://www.biomedcentral.com/1471-2393/9/19</link>
                <dc:creator>Vinita Gurung</dc:creator>
                <dc:creator>Catherine Williamson</dc:creator>
                <dc:creator>Lucy Chappell</dc:creator>
                <dc:creator>Jenny Chambers</dc:creator>
                <dc:creator>Annette Briley</dc:creator>
                <dc:creator>Fiona Broughton-Pipkin</dc:creator>
                <dc:creator>Jim Thornton</dc:creator>
                <dc:source>BMC Pregnancy and Childbirth 2009, 9:19</dc:source>
        <dc:date>2009-05-16T00:00:00Z</dc:date>
        <dc:identifier>doi:10.1186/1471-2393-9-19</dc:identifier>
        <prism:publicationName>BMC Pregnancy and Childbirth</prism:publicationName>
        <prism:issn>1471-2393</prism:issn>
        <prism:volume>9</prism:volume>
        <prism:startingPage>19</prism:startingPage>
        <prism:publicationDate>2009-05-16T00:00:00Z</prism:publicationDate>
                <prism:versionidentifier>XML</prism:versionidentifier>
                <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/" />
    </item>
        <cc:License rdf:about="http://creativecommons.org/licenses/by/2.0/">
        <cc:permits rdf:resource="http://creativecommons.org/ns#Reproduction" />
        <cc:permits rdf:resource="http://creativecommons.org/ns#Distribution" />
        <cc:permits rdf:resource="http://creativecommons.org/ns#DerivativeWorks" />
    </cc:License>
</rdf:RDF>
